Skip to content
OpenCapital
Get started

Supernus Pharmaceuticals SUPN EPS (Diluted)

EPS (Diluted) at other companies

AbbVie logo
AbbVieABBV
$0.39-45.8%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$0.50+11.1%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-$1.26-3.3%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$1.91+2,287%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$4.43+391%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$0.02-81.8%

Other financials

Income statement

See full
Revenue$207.7M+38.6%
Gross profit$184.3M+37.5%
Operating income-$8.3M+18.8%
Net income-$2.3M+80.6%

Balance sheet

See full
Cash & equivalents$186.3M+60.8%
Total debt$40.9M+26.6%
Total equity$1.1B+4.5%
Total assets$1.5B+11.4%

Cash flow

See full
Operating cash flow$66.5M+117%
CapEx--100%
Free cash flow$66.5M+120%

Valuation

See full
Market cap$2.58B+62.8%
Enterprise value$2.44B+62.3%
P/S3.3×+0.9×

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-7.8%-18.9pp
Net margin-3.7%-13.0pp
FCF margin27.9%+3.4pp

Returns & leverage

See full
Return on equity-2.8%-9.1pp
Debt / equity0×0.0×
Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Supernus Pharmaceuticals's EPS (diluted)?
Supernus Pharmaceuticals (SUPN) reported EPS (diluted) of -$0.04 in Q1 2026.
How has Supernus Pharmaceuticals's EPS (diluted) changed year-over-year?
Supernus Pharmaceuticals's EPS (diluted) increased by 81.0% year-over-year, from -$0.21 to -$0.04.
What is the long-term trend for Supernus Pharmaceuticals's EPS (diluted)?
Over 4 years (2021 to 2025), Supernus Pharmaceuticals's EPS (diluted) has grown at a -8.7% compound annual growth rate (CAGR), from $0.98 to -$0.68.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.